Correlation Between Taiwan Chinsan and GeneReach Biotechnology
Can any of the company-specific risk be diversified away by investing in both Taiwan Chinsan and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Taiwan Chinsan and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Taiwan Chinsan Electronic and GeneReach Biotechnology, you can compare the effects of market volatilities on Taiwan Chinsan and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Taiwan Chinsan with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Taiwan Chinsan and GeneReach Biotechnology.
Diversification Opportunities for Taiwan Chinsan and GeneReach Biotechnology
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Taiwan and GeneReach is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Taiwan Chinsan Electronic and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Taiwan Chinsan is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Taiwan Chinsan Electronic are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Taiwan Chinsan i.e., Taiwan Chinsan and GeneReach Biotechnology go up and down completely randomly.
Pair Corralation between Taiwan Chinsan and GeneReach Biotechnology
Assuming the 90 days trading horizon Taiwan Chinsan Electronic is expected to under-perform the GeneReach Biotechnology. In addition to that, Taiwan Chinsan is 2.2 times more volatile than GeneReach Biotechnology. It trades about -0.09 of its total potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.05 per unit of volatility. If you would invest 2,890 in GeneReach Biotechnology on October 30, 2024 and sell it today you would lose (120.00) from holding GeneReach Biotechnology or give up 4.15% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Taiwan Chinsan Electronic vs. GeneReach Biotechnology
Performance |
| Timeline |
| Taiwan Chinsan Electronic |
| GeneReach Biotechnology |
Taiwan Chinsan and GeneReach Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Taiwan Chinsan and GeneReach Biotechnology
The main advantage of trading using opposite Taiwan Chinsan and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Taiwan Chinsan position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.| Taiwan Chinsan vs. Alchip Technologies | Taiwan Chinsan vs. Shinkong Insurance Co | Taiwan Chinsan vs. Feature Integration Technology | Taiwan Chinsan vs. Chinese Gamer International |
| GeneReach Biotechnology vs. Oneness Biotech Co | GeneReach Biotechnology vs. EirGenix | GeneReach Biotechnology vs. Medigen Vaccine Biologics | GeneReach Biotechnology vs. OBI Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |